Grace Therapeutics Statistics
Total Valuation
GRCE has a market cap or net worth of $46.17 million. The enterprise value is $32.42 million.
| Market Cap | 46.17M |
| Enterprise Value | 32.42M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GRCE has 21.04 million shares outstanding. The number of shares has increased by 26.33% in one year.
| Current Share Class | 21.04M |
| Shares Outstanding | 21.04M |
| Shares Change (YoY) | +26.33% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 12.16% |
| Owned by Institutions (%) | 18.39% |
| Float | 15.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.74 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.47
| Current Ratio | 11.47 |
| Quick Ratio | 11.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.19% and return on invested capital (ROIC) is -11.60%.
| Return on Equity (ROE) | -36.19% |
| Return on Assets (ROA) | -10.81% |
| Return on Invested Capital (ROIC) | -11.60% |
| Return on Capital Employed (ROCE) | -21.24% |
| Weighted Average Cost of Capital (WACC) | 6.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.04M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.92% in the last 52 weeks. The beta is 0.43, so GRCE's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -32.92% |
| 50-Day Moving Average | 2.27 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 48.12 |
| Average Volume (20 Days) | 252,675 |
Short Selling Information
The latest short interest is 1.59 million, so 7.56% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.63M |
| Short % of Shares Out | 7.56% |
| Short % of Float | 10.19% |
| Short Ratio (days to cover) | 6.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.37M |
| Pretax Income | -21.92M |
| Net Income | -20.22M |
| EBITDA | -10.36M |
| EBIT | -10.37M |
| Earnings Per Share (EPS) | -$1.20 |
Balance Sheet
The company has $13.76 million in cash and no debt, with a net cash position of $13.76 million or $0.65 per share.
| Cash & Cash Equivalents | 13.76M |
| Total Debt | n/a |
| Net Cash | 13.76M |
| Net Cash Per Share | $0.65 |
| Equity (Book Value) | 48.21M |
| Book Value Per Share | 2.96 |
| Working Capital | 13.08M |
Cash Flow
| Operating Cash Flow | -10.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 7,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.29M |
| FCF Per Share | -$0.49 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GRCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.33% |
| Shareholder Yield | -26.33% |
| Earnings Yield | -44.09% |
| FCF Yield | -22.44% |
Analyst Forecast
The average price target for GRCE is $6.06, which is 176.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.06 |
| Price Target Difference | 176.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 10, 2023. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 10, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |